Urologix Stock Return On Asset
| ULGXDelisted Stock | USD 0.0001 0.00 0.00% |
Urologix fundamentals help investors to digest information that contributes to Urologix's financial success or failures. It also enables traders to predict the movement of Urologix Pink Sheet. The fundamental analysis module provides a way to measure Urologix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Urologix pink sheet.
Urologix |
Urologix Company Return On Asset Analysis
Urologix's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Urologix Return On Asset | -0.0762 |
Most of Urologix's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Urologix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Urologix has a Return On Asset of -0.0762. This is 99.13% lower than that of the Health Care Equipment & Supplies sector and 99.58% lower than that of the Health Care industry. The return on asset for all United States stocks is 45.57% lower than that of the firm.
Urologix Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Urologix's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Urologix could also be used in its relative valuation, which is a method of valuing Urologix by comparing valuation metrics of similar companies.Urologix is currently under evaluation in return on asset category among its peers.
Urologix Fundamentals
| Return On Asset | -0.0762 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 4.92 M | ||||
| Shares Outstanding | 21.82 M | ||||
| Number Of Shares Shorted | 41.23 K | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 14.01 M | ||||
| Gross Profit | 5.9 M | ||||
| EBITDA | (373 K) | ||||
| Net Income | (7.61 M) | ||||
| Cash And Equivalents | 492 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 4.59 M | ||||
| Debt To Equity | (1.81) % | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (0.38) X | ||||
| Cash Flow From Operations | (1.53 M) | ||||
| Short Ratio | 1.02 X | ||||
| Earnings Per Share | (0.22) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 61 | ||||
| Beta | -80.48 | ||||
| Market Capitalization | 82.91 K | ||||
| Total Asset | 5.67 M | ||||
| Retained Earnings | (126.63 M) | ||||
| Working Capital | (612 K) | ||||
| Current Asset | 3.68 M | ||||
| Current Liabilities | 4.29 M | ||||
| Z Score | -28.8 | ||||
| Net Asset | 5.67 M |
About Urologix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Urologix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Urologix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Urologix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Urologix Pink Sheet
If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |